article thumbnail

On Funding?—?Shots on Goal

Both Sides of the Table

On Funding?—?Shots When you’ve been playing the game a bit longer or when you have responsibilities at the fund level you start thinking more about “portfolio construction.” billion When Ring started, even the folks at Shark Tank wouldn’t fund it. Being too early is the same as being wrong.

Funding 294
article thumbnail

TuSimple Prices IPO, Starts Trading Today

socalTECH

San Diego-based TuSimple priced its IPO last night, saying that it will sell 33,783,783 shares of its Class A common stock at the price of $40.00 Composite Capital Master Fund, and Navistar. per share, raising just over $1 billion for the company. TuSimple's IPO was underwritten by Morgan Stanley, Citigroup and J.P.

Pricing 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Odonate Therapeutics Prices IPO

socalTECH

San Diego-based Odonate Therapeutics , a pharmaceuticals startup focused on chemotherapy drugs, has priced its IPO, saying on Wednesday afternoon that it has priced its IPO at $24.00 per share was on the low end of its initial estimated pricing range of $24.00 The $24.00 READ MORE>>.

Pricing 113
article thumbnail

AnaptysBio Sets Estimated IPO Pricing Range

socalTECH

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 and $16.00 The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB. as early as Thursday.

Pricing 100
article thumbnail

Ambit Biosciences Prices IPO

socalTECH

San Diego-based Ambit Biosciences has priced its IPO, saying that it is offering up 8,125,000 shares of its common stock at $8.00 Ambit priced well below its estimated initial public offering range, which had been set at between $13.00 ambit biosciences lifescience merger acquisition' and $15.00 READ MORE>>.

Pricing 138
article thumbnail

Receptos Sets Estimated IPO Pricing Range

socalTECH

San Diego-based biopharmaceuticals developer Receptos has set the initial, estimated pricing range for its IPO, saying in a filing Thursday that it now expects its IPO pricing to be between $14.00 Receptos is venture backed by ARCH Venture Partners, Flagship Ventures, Lilly Ventures Fund, Polaris Ventures, and Venrock Associates.

Pricing 153
article thumbnail

Green Dot Sets Pricing Range

socalTECH

Monrovia-based Green Dot , the provider of prepaid debit cards, has set pricing on its IPO, saying in a filing Friday that it estimates and initial public offering price of between $32.00 Green Dot filed for an IPO in February, and is backed by Sequoia Capital, TTP Fund, and the Tech Coast Angeles. and $35.00 READ MORE>>.

Pricing 213